Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method

[Display omitted] •Development and optimization of RP UHPLC method with UV detection for stability testing of nepafenac.•Significant degradation was observed in acid, base and oxidative conditions.•Structures of major degradation products were proposed based on mass spectrometry analysis.•Degradatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 2016-05, Vol.123, p.42-52
Hauptverfasser: Runje, Mislav, Babić, Sandra, Meštrović, Ernest, Nekola, Irena, Dujmić-Vučinić, Željka, Vojčić, Nina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Development and optimization of RP UHPLC method with UV detection for stability testing of nepafenac.•Significant degradation was observed in acid, base and oxidative conditions.•Structures of major degradation products were proposed based on mass spectrometry analysis.•Degradation pathways of nepafenac were elucidated.•High sensitivity and efficient separation in only 5min were achieved. This paper presents stability study of the nonsteroidal anti-inflammatory drug (NSAID) nepafenac. In order to investigate stability of nepafenac, it was subjected to forced degradation under different stress conditions: acid and base hydrolysis, oxidation, humidity, heat and light. A novel stability indicating reverse phase ultra high performance liquid chromatographic (UHPLC) method coupled to ultraviolet detector has been developed to separate nepafenac and all related compounds (2-aminobenzophenone, Cl-thionepafenac, thionepafenac, Cl-nepafenac, hydroxy-nepafenac, and cyclic-nepafenac). Efficient chromatographic separation was achieved on a Waters Acquity BEH C18 stationary phase with a gradient elution. Quantification was carried out at 235nm at a flow rate of 0.6mL/min−1. The resolution between nepafenac and six potential impurities is found to be greater than 2.0. The developed method was validated with respect to specificity, LOD, LOQ, linearity, precision, accuracy and robustness. The r2 values for nepafenac and six potential impurities were all greater than 0.999. The developed method is capable to detect impurities of nepafenac at a level of 0.005% with respect to test concentration of 1.0mg/mL. Significant degradation is observed in acid, base and oxidative degradation conditions and degradation products (DPs) were identified using mass spectrometry analysis; two of them were found to be a known process related impurities (hydroxy- and cyclic-nepafenac) whereas four degradation products were identified as new degradation impurities. The forced degradation samples were assayed against a qualified reference standard and the mass balance was found to be close to 99.5%.
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2016.02.003